sotorasib,divarasib,adagrasib,cetuximab
amgen,mirati therapeutics,roche,eli lilly
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', '#gi', 'sotorasib', 'gi ', 'adagrasib', 'gdc-6036', 'adaptive ']
#wcgic2023 emerging targets in #gi cancer dr. van cutsem and dr. carnero dr. strickler kras inhibitors: sotorasib, adagrasib, divarasib adaptive feedback increasing #shp2 #egfr #nras #hras dual or triple inhibition might overcome #resistance
#research 
Medical Oncologist MD, Vall d'Hebron @vallhebron @VHIO
Drug Development

Vocal Junta Govern @COMBarcelona

Asesor @SalutUIC
#GBM #PhaseI #oncology